Join Mailing List   |   Print Page   |   Contact Us   |   Sign In   |   Join
Thrombosis and Haemostasis - Volume 81 - Volume 88
Share |

Thrombosis and Haemostasis

Volume 88 (2002)

Manco-Johnson MJ, Grabowski EF, Hellgreen M, Kemahli AS, Massicotte MP, Muntean W, Peters M, Nowak-Göttl U. Laboratory Testing for Thrombophilia in Pediatric Patients. Thromb Haemost 2002; 88: 155-156.

Manco-Johnson MJ, Grabowski EF, Hellgreen M, Kemahli AS, Massicotte MP, Muntean W, Peters M, Schlegel N, Wang M, Nowak-Göttl U. Recommendations for tPA Thrombolysis in Children. Thromb Haemost 2002; 88: 157-158.

Volume 87 (2002)

Frojmovic M, Nash G Definitions in Biorheology: Cell Aggregation and Cell Adhesion in Flow. Thromb Haemost 2002; 87: 771.

Greaves M. Limitations of the Laboratory Monitoring of Heparin Therapy. Thromb Haemost 2002, 87: 163-5.

Jackson CM, White II GC, Barrowcliffe T, Esnouf MP, Jespersen J, Kluft C, Lenahan J. A Reference System Approach to Future Standardization of Laboratory Tests for Hemostasis. Thromb Haemost 2002, 87: 165-170.

Volume 86 (2001)

Taylor Jr FB, Toh C-H, Hoots WK, Wada H, Levi M. Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation. Thromb Haemost 2001, 86: 1327-30.

Levi M, Dörffler-Melly J, Johnson GJ, Drouet L, Badimon L. Usefulness and Limitations of Animal Models of Venous Thrombosis. Thromb Haemost 2001, 86: 1331-33.

Kini RM, Morita T, Rosing J. Classification and Nomenclature of Prothrombin Activators Isolated from Snake Venoms. Thromb Haemost 2001, 86: 710-11.

Mazurier C, Rodeghiero F. Recommended Abbreviations for von Willebrand Factor and Its Activities. Thromb Haemost 2001, 86: 712.

Volume 85 (2001)

Goodeve AC, Eikenboom JCJ, Ginsburg D, Hilbert L, Mazurier C, Peake IR, Sadler BJE, Rodeghiero F. A Standard Nomenclature for von Willebrand Factor Gene Mutations and Polymorphisms. Thromb Haemost 2001; 85: 929-931.

White II GC, Rosendaal F, Aledort LM, Luscher JM, Rothschild C, Ingerslev J. Definitions in Hemophilia. Thromb Haemost 2001; 85: 560-75.

Kini RM, Chow G. Exogenous Inhibitors of Platelet Aggregation from Animal Sources. Thromb Haemost 2001, 85: 179-81.

Chow G, Kini RM. Exogenous Factors from Animal Sources that Induce Platelet Aggregation. Thromb Haemost 2001, 85: 177-8 .

Volume 84 (2000)

Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, Lind B, Mannhalter C, Pabinger I, Reitsma PH, Formstone C, Cooper DN, Saito H, Suzuki K, Bernardi F, Aiach M. Protein S Deficiency: A Database of Mutations--Summary of the First Update. Thromb Haemost 2000, 84: 918-934.

Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE. Acquired von Willebrand Syndrome--Data from an International Registry. Thromb Haemost 2000, 84: 345-49 .

Volume 83 (2000)

No official communications published.

Volume 82 (1999)

McCarron BI, Marder VJ, Kanouse JJ, Francis CW. A Soluble Fibrin Standard: Comparabile Dose-response with Immunologic and Functional Assays. Thromb Haemost 1999, 82:145-48 .

Volume 81 (1999)

Sutor AH, von Kries R, Cornelissen EAM, McNinch AW, Andrew M . Vitamin K Deficiency Bleeding (VKDB) in Infancy. Thromb Haemost 1999; 81:456-61.

White GC, DiMichele D, Mertens K, Negrier C, Peake IR, Prowse C, Schwaab R, Yoshioka A, Ingerslev J. Utilization of Previously Treated Patients (PTPs), Noninfected Patients (NIPs), and Previously Untreated Patients (PUPs) in the Evaluation of New Factor VIII and Factor IX Concentrates. Thromb Haemost 1999; 81: 462 .

Arocha-Piñango CL, Marchi R, Guerrero B. Inventory of Exogenous Hemostatic Factors Derived from Arthropods. Thromb Haemost 1999; 81: 647-56.

Johnson GJ, Griggs TR, Badimon L. The Utility of Animal Models in the Preclinical Study of Interventions to Prevent Human Coronary Artery Restenosis: Analysis and Recommendations. Thromb Haemost 1999; 81: 835-43 .

Membership Management Software Powered by®  ::  Legal